BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21054151)

  • 1. Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005: an analysis of 21 734 cases.
    Bazzeh F; Rihani R; Howard S; Sultan I
    Leuk Lymphoma; 2010 Dec; 51(12):2198-207. PubMed ID: 21054151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
    Ali S; Olszewski AJ
    Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
    Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
    Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
    Gerber NK; Atoria CL; Elkin EB; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Mortality in Children and Adolescents with Hodgkin's Lymphoma: A Surveillance, Epidemiology and End Results Analysis.
    Amini A; Murphy B; Cost CR; Garrington TP; Greffe BS; Liu AK
    J Adolesc Young Adult Oncol; 2016 Jun; 5(2):181-6. PubMed ID: 26959398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
    Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
    BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.
    Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
    Acta Oncol; 2018 Feb; 57(2):276-282. PubMed ID: 28760045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma in children: experience in a tertiary care centre in India.
    Trehan A; Singla S; Marwaha RK; Bansal D; Srinivasan R
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):174-9. PubMed ID: 23073046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies.
    Xavier AC; Costa LJ
    Leuk Lymphoma; 2015; 56(8):2339-43. PubMed ID: 25393805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals.
    Al-Salam S; John A; Daoud S; Chong SM; Castella A
    Leuk Lymphoma; 2008 Sep; 49(9):1769-77. PubMed ID: 18661399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Presentation and Outcome in 100 Pediatric Hodgkin Lymphoma Patients Treated at Children Hospital, Lahore, Pakistan and Royal Marsden Hospital, UK.
    Faizan M; Taj MM; Anwar S; Asghar N; Ahmad A; Lancaster D; Atra A; Ali AS
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):904-907. PubMed ID: 27981925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
    Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
    Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.
    Sultan I; Qaddoumi I; Yaser S; Rodriguez-Galindo C; Ferrari A
    J Clin Oncol; 2009 Jul; 27(20):3391-7. PubMed ID: 19398574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of primary lymph node sites in survival and mortality prediction in Hodgkin lymphoma: a SEER population-based retrospective study.
    Ebied A; Thanh Huan V; Makram OM; Sang TK; Ghorab M; Ngo HT; Iraqi A; Kamel MG; Dang TN; Vuong NL; Hirayama K; Huy NT
    Cancer Med; 2018 Apr; 7(4):953-965. PubMed ID: 29520977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.
    Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH
    Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in non-Hodgkin lymphoma survival between young adults and children.
    Tai E; Pollack LA; Townsend J; Li J; Steele CB; Richardson LC
    Arch Pediatr Adolesc Med; 2010 Mar; 164(3):218-24. PubMed ID: 20194253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
    Koh YW; Yoon DH; Suh C; Huh J
    Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.